Herpes Simplex Virus Type 1 (HSV-1) pUL37 monoclonal antibody CB8
Mouse CD4 epitope A monoclonal antibody YTS 177.9.6.1
CD19 membrane protein of mouse B lymphocytes monoclonal antibody 6D5
Herpes Simplex Virus Type 1 and 2 (HSV-1 and -2) VP16 (tegument) monoclonal antibody LP1 (anti-HSV VP16)
Human CD11a monoclonal antibody YTH 81.5
Human CD7 monoclonal antibody YTH 30.15
Mouse heat stable antigen monoclonal antibody YBM 5.10.4
Mouse CD71 monoclonal antibody YTA 74.4.4
Mouse CD18 monoclonal antibody YTS 213.1.1
Mouse CD8 (lyt-2) monoclonal antibody YTS 105.18.10
Mouse CD4 epitope B monoclonal antibody YTA 3.1.2
Human CD59 monoclonal antibody YTH 53.1
Human CD28 monoclonal antibody YTH 913.12
Human CD45R monoclonal antibody YTH 80.103
Human CD59 monoclonal antibody YTH 53.1
Human Leukocyte Antigen B (HLA-B) monoclonal antibody YTH 76.3
Human CD235a monoclonal antibody YTH 89.1
Herpes Simplex Virus Type 1 (HSV-1) VP21/VP22a (scaffold) monoclonal antibody LP13
Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein H monoclonal antibody BBH1
Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein B monoclonal antibody CB24
Sheep immunoglobulin G monoclonal antibody SIg 375
Rat insulin receptor substrate-1 monoclonal antibody IRS 8-63
Human Insulin-like growth factor-1 receptor monoclonal antibody IGF 1R 1-2
Human insulin receptor monoclonal antibody IR 18-34
Rat IgG2b monoclonal antibody NORIg 7.16.2
Human HLA-class I monoclonal antibody YTH 862.2
Rat CD45 monoclonal antibody YTH 24.5
Mouse Thy-1 monoclonal antibody YBM 29.2.1
Mouse CD8 (lyt-3) monoclonal antibody YTS 156.7.7
Mouse Thy-1 monoclonal antibody YTS 154.7.7.10
Human Leukocyte Antigen B (HLA-B) monoclonal antibody YTH 76.3
KARPAS 384 Human T-cell non-Hodgkin’s Lymphoma cell line
KARPAS 384 Human T-cell non-Hodgkin’s Lymphoma cell line useful in oncology research, developed at the University of Cambridge.
1 licensing option
KARPAS 422 Human B-cell Non-Hodgkin’s Lymphoma Cell Line
KARPAS 422 Human B-cell Non-Hodgkin’s Lymphoma cell line useful in oncology research, developed at the University of Cambridge
1 licensing option
KARPAS 299 Lymphoma Cell Line
Human Non-Hodgkin's Ki-positive Large Cell Lymphoma cell lines
1 licensing option